Corcept Director Sells Shares Amid Stock Recovery
James N. Wilson, a director at Corcept Therapeutics (CORT), sold 10,000 shares on July 15, 2026, as part of a pre-established trading plan under Rule 10b5-1 to avoid insider trading concerns. The stock had recovered with a one-year return of about 25% at the time.
Tickers: $CORT